CIK 0001388320 · Non-accelerated filer<br>Smaller reporting company
Actinium Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ATNM
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880378336
- Phone
- (646) 677-3870
- Business address
- 100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
- Former names
- Cactus Ventures, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-04-15 | Steinhart Richard I Director | Grant or award · Options to purchase common stock | +75,000 | $1.99 | $149K | 75,000 |
| 2016-04-15 | TRAVERSA SERGIO Director | Purchase | +1,000 | $2.02 | $2K | 3,000 |
| 2016-04-15 | TRAVERSA SERGIO Director | Grant or award · Options to purchase common stock | +75,000 | $1.99 | $149K | 75,000 |
| 2016-04-14 | Nicholson, C. David Director | Purchase | +5,000 | $2.00 | $10K | 15,000 |
| 2016-04-14 | DAVE KAUSHIK J CEO and Interim CFO | Purchase | +8,000 | $2.02 | $16K | 86,500 |
| 2016-04-14 | DAVE KAUSHIK J CEO and Interim CFO | Purchase | +2,000 | $2.01 | $4K | 88,500 |
| 2016-04-14 | SETH SANDESH Director | Purchase | +5,000 | $2.00 | $10K | 15,000 |
| 2016-04-14 | Steinhart Richard I Director | Purchase | +2,500 | $2.01 | $5K | 2,500 |
| 2016-04-14 | TRAVERSA SERGIO Director | Purchase | +2,000 | $2.02 | $4K | 2,000 |
| 2015-05-07 | DAVE KAUSHIK J President, CEO and Interim CFO | Shares withheld for taxes | −7,083 | $2.45 | $17K | 57,083 |
| 2015-05-07 | DAVE KAUSHIK J President, CEO and Interim CFO | Returned to the company | −27,501 | $2.45 | $67K | 57,083 |
| 2015-05-07 | DAVE KAUSHIK J President, CEO and Interim CFO | Shares withheld for taxes | −16,000 | $2.45 | $39K | 73,083 |
| 2015-05-07 | DAVE KAUSHIK J President, CEO and Interim CFO | Returned to the company | −68,000 | $2.45 | $167K | 73,083 |
| 2015-05-07 | DAVE KAUSHIK J President, CEO and Interim CFO | Shares withheld for taxes | −12,500 | $2.45 | $31K | 85,583 |
| 2015-05-07 | DAVE KAUSHIK J President, CEO and Interim CFO | Returned to the company | −25,000 | $2.45 | $61K | 85,583 |
| 2015-05-07 | DAVE KAUSHIK J President, CEO and Interim CFO | Grant or award · Options to purchase common stock | +82,128 | $2.52 | $207K | 82,128 |
| 2015-05-07 | DAVE KAUSHIK J President, CEO and Interim CFO | Grant or award · Options to purchase common stock | +63,063 | $2.52 | $159K | 63,063 |
| 2015-05-07 | CICIC DRAGAN COO and Chief Medical Officer | Shares withheld for taxes | −560 | $2.52 | $1K | 560 |
| 2015-05-07 | CICIC DRAGAN COO and Chief Medical Officer | Returned to the company | −2,380 | $2.52 | $6K | 560 |
| 2015-05-07 | CICIC DRAGAN COO and Chief Medical Officer | Grant or award · Options to purchase common stock | +2,874 | $2.52 | $7K | 2,874 |
Page 15 of 16 · 316 trades